Neutrophil apoptosis induced by proteolytic enzymes.
In this study, we show that three proteolytic enzymes of different specificity-pronase, chymotrypsin, and trypsin-induced a dramatic stimulation of neutrophil apoptosis as shown by morphologic characteristics, analysis of cell DNA content, and presence of a characteristic "ladder" pattern of DNA fragmentation. The action of either chymotrypsin or trypsin was completely prevented by the serine protease inhibitor aprotinin, indicating that the proteolytic activity of the enzymes accounts for apoptosis induction. Stimulation of neutrophil apoptosis by proteases was observed in culture medium supplemented with either inactivated fetal calf serum (0.1-50%), autologous serum (0.1-50%), bovine serum albumin (0.1%), or in protein-free medium. Other cell types such as human peripheral blood monocytes and lymphocytes, human leukemic cells from THP-1, HL-60 and K562 lines, murine L929 fibroblasts, and unstimulated murine macrophages harvested from the peritoneal cavity were not induced to undergo apoptosis after the treatment with proteases. In an attempt to determine whether neutrophil serine proteases could induce apoptosis as chymotrypsin and trypsin do, the effect of elastase was assessed. A significant increase in the percentage of apoptotic cells was observed in elastase-treated neutrophils. We propose that the selective stimulation of neutrophil apoptosis by proteolytic enzymes may play an important role in the normal resolution of inflammation by limiting the autotoxic potential of the neutrophil.
Trevani
A S
AS
Institute of Hematologic Research, National Academy of Medicine, Buenos Aires, Argentina.
Andonegui
G
G
Giordano
M
M
Nociari
M
M
Fontán
P
P
Dran
G
G
Geffner
J R
JR
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D007611:Aprotinin / Q000494:pharmacology; D002417:Cattle; D002918:Chymotrypsin / Q000494:pharmacology; D003470:Culture Media; D004247:DNA / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D007249:Inflammation / Q000473:pathology / Q000503:physiopathology; D019272:Leukocyte Elastase; D009504:Neutrophils / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D010196:Pancreatic Elastase / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011402:Pronase / Q000494:pharmacology; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D012710:Serum Albumin, Bovine; D014357:Trypsin / Q000494:pharmacology
D003470:Culture Media; D015842:Serine Proteinase Inhibitors; D012710:Serum Albumin, Bovine; D004247:DNA; D007611:Aprotinin; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D010196:Pancreatic Elastase; D019272:Leukocyte Elastase; D014357:Trypsin; D011402:Pronase